指南与共识腹部技术与安全MR

比较四种肝细胞癌诊断指南在钆塞酸增强肝脏MRI中的诊断性能

Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
指南 / 共识 · Radiology · 2024-01-01

该回顾性研究纳入韩国11家三级医院2237例高危患者的2445个局灶性肝脏病灶,由4名放射科医师依据AASLD/LI-RADS、KLCA-NCC、EASL和APASL四种指南独立判读钆塞酸增强MRI。KLCA-NCC准确率最高(80.0%),东方指南敏感度较高(APASL 89.1%、KLCA-NCC 78.2%),西方指南特异度较高(AASLD/LI-RADS 89.6%、EASL 88.1%),读者综合判断准确率(86.0%)高于各指南。

要点

  • 东方指南(APASL、KLCA-NCC)敏感度较高,西方指南(AASLD/LI-RADS、EASL)特异度较高。
  • KLCA-NCC准确率最高(80.0%),AASLD/LI-RADS诊断比值比最高(20.7)。
  • 读者综合判断准确率86.0%,高于四种指南中的任何一种。

核心结论

  • 四种国际肝细胞癌诊断指南中,东方指南敏感度较高而西方指南特异度较高;KLCA-NCC准确率最高,AASLD/LI-RADS诊断比值比最高,读者综合判断准确率高于各指南。

研究设计与样本

  • 回顾性研究,纳入韩国11家三级医院2015年1月至2018年6月未治疗、有肝细胞癌风险并接受钆塞酸增强MRI的患者2237例(平均年龄59岁±11[SD],男性1666例),分析局灶性肝脏病灶2445个(中位大小27.4 mm),由4名放射科医师独立依据四种指南判读;恶性病灶经病理证实,良性病灶采用组织学及临床随访数据。

诊断标准与关键数值

  • KLCA-NCC准确率80.0%(95%CI:78.7,81.2;P=.001);APASL敏感度89.1%(95%CI:87.8,90.3),KLCA-NCC敏感度78.2%(95%CI:76.6,79.7);AASLD/LI-RADS特异度89.6%(95%CI:87.8,91.2),EASL特异度88.1%(95%CI:86.2,89.9)(P=.001);诊断比值比AASLD/LI-RADS 20.7(95%CI:17.0,25.3)、KLCA-NCC 18.9(95%CI:15.8,22.6)、EASL 16.8(95%CI:13.8,20.4)、APASL 8.9(95%CI:7.4,10.7);读者判断准确率86.0%(95%CI:84.9,86.9;P=.001)。

临床应用与阅片要点

  • 在钆塞酸增强MRI判读肝细胞癌时,可参考东方指南侧重敏感度、西方指南侧重特异度的差异,KLCA-NCC准确率最高、AASLD/LI-RADS诊断比值比最高,读者综合判断准确率高于各指南。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Noninvasive diagnostic guidelines for hepatocellular carcinoma (HCC) vary across different global geographic areas, especially regarding criteria about gadoxetic acid-enhanced MRI. Purpose To compare the diagnostic performance of four different international HCC diagnosis guidelines and readers' judgment in diagnosing HCC using gadoxetic acid-enhanced MRI in patients at high risk for HCC. Materials and Methods This retrospective study included patients who had not undergone treatment, were at risk for HCC, and who underwent gadoxetic acid-enhanced MRI from January 2015 to June 2018 from 11 tertiary hospitals in South Korea. Four radiologists independently reviewed focal liver lesions (FLLs) according to four guidelines: American Association for the Study of Liver Diseases (AASLD)/Liver Imaging Reporting and Data System (LI-RADS), Korean Liver Cancer Association-National Cancer Center (KLCA-NCC), European Association for the Study of the Liver (EASL), and Asian Pacific Association for the Study of the Liver (APASL). Reader judgment (HCC or not HCC) was also recorded. Malignant FLLs were confirmed at pathology, and histologic and clinical follow-up data were used for benign FLLs. The guidelines' diagnostic performance was compared using generalized estimating equations. Additionally, the diagnostic odds ratio was assessed. Results A total of 2445 FLLs (median size, 27.4 mm) were analyzed in 2237 patients (mean age, 59 years ± 11 [SD]; 1666 male patients); 69.3% (1694 of 2445) were HCCs. KLCA-NCC showed the highest accuracy (80.0%; 95% CI: 78.7, 81.2; P = .001), with high sensitivity in Eastern guidelines (APASL, 89.1% [95% CI: 87.8, 90.3]; KLCA-NCC, 78.2% [95% CI: 76.6, 79.7]) and high specificity in Western guidelines (AASLD/LI-RADS, 89.6% [95% CI: 87.8, 91.2]; EASL, 88.1% [95% CI: 86.2, 89.9]) (P = .001). The diagnostic odds ratios were 20.7 (95% CI: 17.0, 25.3) for AASLD/LI-RADS, 18.9 (95% CI: 15.8, 22.6) for KLCA-NCC, 16.8 (95% CI: 13.8, 20.4) for EASL, and 8.9 (95% CI: 7.4, 10.7) for APASL. The readers' judgment demonstrated higher accuracy than that of the guidelines (accuracy, 86.0%; 95% CI: 84.9, 86.9; P = .001). Conclusion Among four different international HCC diagnosis guidelines, Eastern guidelines demonstrated higher sensitivity, whereas Western guidelines displayed higher specificity. KLCA-NCC achieved the highest accuracy, and AASLD/LI-RADS exhibited the highest diagnostic odds ratio. © RSNA, 2024 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yoon JH, Kim YK, Kim JW, et al. Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI. Radiology. 2024. PMID: 38563667. doi:10.1148/radiol.233114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。